Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rekombinanter CTLA4 Antikörper

Dieses Humanized Monoklonal-Antikörper erkennt spezifisch CTLA4 in FACS, WB und ELISA. Er zeigt eine Reaktivität gegenüber Human.
Rockland
Produktnummer ABIN7540550
Hersteller Produkt- Nr.: 400-001-mt1

Kurzübersicht für Rekombinanter CTLA4 Antikörper (ABIN7540550)

Target

Alle CTLA4 Antikörper anzeigen
CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4))

Antikörpertyp

Recombinant Antibody

Fragment

Fab fragment

Reaktivität

  • 152
  • 84
  • 45
  • 14
  • 3
Human

Wirt

  • 91
  • 80
  • 22
  • 7
  • 1
  • 1
  • 1
  • 1
  • 1
Humanized

Klonalität

  • 129
  • 72
  • 3
Monoklonal

Konjugat

  • 108
  • 18
  • 13
  • 11
  • 9
  • 5
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser CTLA4 Antikörper ist unkonjugiert

Applikation

  • 96
  • 90
  • 62
  • 59
  • 45
  • 36
  • 19
  • 13
  • 10
  • 7
  • 6
  • 6
  • 4
  • 4
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Flow Cytometry (FACS), Western Blotting (WB), ELISA

Klon

Abz521
  • Hersteller Produkt- Nr.

    400-001-mt1

    Hersteller

    Rockland

    Verwendungszweck

    Recombinant Anti-CTLA4 Fab Antibody

    Kreuzreaktivität (Details)

    The purity was estimated to be >95 % by SDS-PAGE analysis.

    Aufreinigung

    Humanized Recombinant CLTA4 Fab fragment was expressed in CHO cells.

    Sterilität

    Sterile filtered

    Isotyp

    IgG1
  • Applikationshinweise

    ELISA_Dilution: User Optimized

    Flow_Cytometry_Dilution: User Optimized

    Western_Blot_Dilution: User Optimized

    Kommentare

    Humanized Recombinant Anti-CTLA-4 Fab fragment Antibody is tested for use in Flow Cytometry, Western Blot, and ELISA. This antibody recognizes structured CTLA-4 and will work in western blot when the protein has not been denatured with DTT or bMe. Although not tested, this antibody could be useful in in IHC and in in-vivo and other cellular assays. Specific conditions for reactivity should be optimized by the end user.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Buffer

    Buffer: 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2

    Stabilizer: 30 % Glycerol

    Preservative: None

    Konservierungsmittel

    Without preservative

    Lagerung

    4 °C

    Informationen zur Lagerung

    Store vial at 2-8° C. Dilute only prior to immediate use.

    Haltbarkeit

    6 months
  • Target

    CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4))

    Andere Bezeichnung

    CTLA4

    Hintergrund

    Cytotoxic T-Lymphocyte Associated Protein 4, Ipilimumab, Yervoy, recombinant Monoclonal CTLA4, RabMAb CTLA4, CTLA-4, CD152, Insulin-Dependent Diabetes Mellitus 12, Cytotoxic T-Lymphocyte Protein 4, Celiac Disease 3, GSE, CD, Ligand And Transmembrane Spliced, Cytotoxic T Lymphocyte Associated Antigen 4, Cytotoxic T Lymphocyte Associated Antigen 4 Short Spliced Form, Cytotoxic T-Lymphocyte-Associated Serine Esterase-4, Cytotoxic T-Lymphocyte-Associated Antigen 4, CD152 Isoform, CD152 Antigen, CELIAC3, IDDM12, ALPS5, GRD4,CTLA-4 (Cytotoxic T-Lymphocyte Antigen 4) is also known as CD152 (Cluster of differentiation 152), is a protein receptor that functions as an immune checkpoint and downregulates immune responses. CTLA4 is constitutively expressed in regulatory T cells but only upregulated in conventional T cells after activation - a phenomenon which is particularly notable in cancers. It acts as an "off" switch when bound to CD80 or CD86 on the surface of antigen-presenting cells. CTLA4 is a member of the immunoglobulin superfamily. The protein contains an extracellular V domain, a transmembrane domain, and a cytoplasmic tail. Alternate splice variants, encoding different isoforms. CTLA4 is similar to the T-cell co-stimulatory protein, CD28, and both molecules bind to CD80 and CD86, also called B7-1 and B7-2 respectively, on antigen-presenting cells. CTLA4 transmits an inhibitory signal to T cells, whereas CD28 transmits a stimulatory signal. Intracellular CTLA4 is also found in regulatory T cells and may be important to their function. T cell activation through the T cell receptor and CD28 leads to increased expression of CTLA-4, an inhibitory receptor for B7 Molecules. Fusion proteins of CTLA4 and antibodies (CTLA4-Ig) have been used in clinical trials for rheumatoid arthritis. This antibody is made from a humanized Fab fragment of anti-CTLA4, ipilimumab or Yervoy, the first FDA approved immune checkpoint blockade therapy for cancer treatment. Humanized Recombinant Anti-CTLA4 fragment Antibody is useful for researchers interested in cancer research, immunodeficiency, and autoimmune diseases.

    Gen-ID

    1493

    NCBI Accession

    NP_001032720

    UniProt

    P16410

    Pathways

    Cancer Immune Checkpoints
Sie sind hier:
Chat with us!